More than 20 years of experience in global clinical trial operation and management in Roche、Bristol-Myers Squibb and INC Research (CRO). As a senior manager she provide strategy and solution for local and Asia-pacific Pharmaceutical companies go to the world and compete in the global market.
Charles has 30+ years of experience in medical research and pharmaceutical industry. He was physician and professor at Santa Casa Medical School of Sao Paulo (one of the most prestigious medical schools in Brazil), founder of the Brazilian Association of CROs, and Vice President of the Brazilian Association of Pharmaceutical Physicians. He also served in leadership roles for 20+ years at several global CROs like Quintiles, PRA. PhD in Pediatric Infectious Disease.
PhD. in Pathobiology, University of Southern California.
Hematopathology Fellowship, City of Hope Medical Center, 2013-2014.
Attending Hematopathologist and Laboratory Director, Kaleida Health, 2014-2018. Assistant Professor and Associate Residency Program Director, University at Buffalo, SUNY, Department of Pathology, 2014-2018.
President, Western New York Society of Pathologist, 2019-2020.
Director of Hematology, Flow Cytometry, Advanced Coagulation, and Blood Bank, Rochester General Hospital, 2019- 2020.
Laboratory Medical Director, ACM Global laboratories, 2018 – 2020.
Hematopathology Fellowship, City of Hope Medical Center, 2013-2014.
Attending Hematopathologist and Laboratory Director, Kaleida Health, 2014-2018. Assistant Professor and Associate Residency Program Director, University at Buffalo, SUNY, Department of Pathology, 2014-2018.
President, Western New York Society of Pathologist, 2019-2020.
Director of Hematology, Flow Cytometry, Advanced Coagulation, and Blood Bank, Rochester General Hospital, 2019- 2020.
Laboratory Medical Director, ACM Global laboratories, 2018 – 2020.
Ricardo Sobhie Diaz is an infectious diseases-trained physician who conducts translational research in HIV/AIDS. He is a professor of Federal University of Sao Paulo, Brazil, and has over 150 articles published in peer-reviewed scientific journals.He is also a member of the “Brazilian Consensus Guidelines for Antiretrovirals for Adults and Adolescents of the Brazilian Ministry of Health”, and acts as a consultant in the area of Laboratory of STD/AIDS and Viral Hepatitis Department for the Brazilian Ministry of Health.
PhD in physical chemistry from the University of California, Davis. Joined Frontage Laboratories in 2008. Xiaonan is the lead for project management and operations under the regulated environment, his expertise lies in the planning, execution and quality control of projects in the bioanalytical department at Frontage. Xiaonan has extensive experiences in method development, validation, and sample analysis, he has supported over 400 nonclinical (GLP, non-GLP) and clinical bioanalytical projects.
PhD from the University of Connecticut in 1993. Former Regulatory Reviewer of United States FDA. Since 2006, Dr. Sun co-founded Tasly Pharmaceuticals Inc in the US to lead the efforts of innovative medicine developments seeking FDA/EMA approvals. Dr. Sun had led his group completed the worldwide first and only phase III global clinical trial of a multi-herb drug product under FDA/EMA regulations, and has supported 2 vaccines, 1 monoclonal antibody, 3 botanicals, and 1 stem cell-based products to conduct clinical trials in the USA and EU to fight against COVID-19.
Sponsors:
Tigermed is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally.
Frontage, a Tigermed company, provides integrated, science-driven product development services throughout the drug discovery and development process to enable life science innovation.